PTC Inc. (PTC) Q1 2026 earnings review
Strategic Subtraction: Selling IoT to Fund Buybacks Amid Deceleration
PTC announced a definitive agreement to sell its Kepware and ThingWorx businesses for ~$725M to focus entirely on its 'Intelligent Product Lifecycle' (CAD, PLM, ALM, SLM). While Q1 headline Revenue surged 21%, this is an accounting mirage driven by longer contract terms (ASC 606); the true health metric, Constant Currency ARR, decelerated to 8.4% growth (9.0% organic ex-divestiture). Management is countering the slowing top line with massive capital returns, targeting ~$1.2B in FY26 buybacks. The thesis has shifted from high-growth SaaS to a cash-generative, disciplined compounder.
🐂 Bull Case
PTC is deploying its balance sheet aggressively. With ~$365M in net proceeds from the divestiture and strong FCF, they plan to repurchase $1.115B - $1.315B in stock for FY26. This represents a significant yield for shareholders.
Exiting the IoT business (Kepware/ThingWorx) removes a lower-growth, non-core distraction. The remaining portfolio (CAD, PLM, ALM) has a stronger 'right to win' and better margin profile.
🐻 Bear Case
Despite the 'strategic focus' narrative, the core business is decelerating. ARR growth has slid from 11% in 25Q1 to 8.4% in 26Q1, with Q2 guidance implying a further drop to ~7.75%. FY26 net new ARR guidance is effectively flat.
Q1 Revenue grew 21% while ARR grew 8%. This massive disconnect is due to ASC 606 and longer contract terms (3 years vs 2 years). Investors focusing on the P&L headlines are missing the weaker underlying consumption trends.
⚖️ Verdict: ⚪
Neutral. The divestiture and buybacks put a floor under the stock, but the relentless deceleration of ARR growth prevents a higher rating. Until the 'focused' portfolio proves it can re-accelerate organic growth back to double digits, this is a financial engineering story rather than a growth story.
Key Themes
The ASC 606 Mirage
A major discrepancy exists between reported Revenue (+21%) and ARR (+8.4%). Management admitted this was driven by a shift in average contract duration from ~2 years to ~3 years, which pulls revenue forward under ASC 606. While this boosts reported EPS and Operating Income, it does not reflect an acceleration in business momentum. Investors must ignore the revenue beat and focus on the decelerating ARR.
Strategic Pivot: Abandoning IoT
The sale of Kepware and ThingWorx marks the end of PTC's industrial IoT experiment. These assets contributed ~$160M ARR but were deemed non-essential to the 'Product Data Foundation' strategy. This move allows PTC to double down on CAD, PLM, and ALM, but it also creates a short-term growth headwind (removing 8-9% of revenue) and potential disruption risks during the transition.
Trend Deceleration Continues
ARR growth has declined for five consecutive quarters (11% -> 10% -> 9.3% -> 8.5% -> 8.4%). Guidance for Q2'26 suggests a further drop to 7.5%-8.0%. While management cites 'discipline' and 'macro,' the persistent slide suggests the core Go-To-Market transformation is struggling to offset broader headwinds.
Shareholder Returns Unlocked
Management is utilizing the divestiture to aggressively return capital. They repurchased $200M in Q1 and plan for $150M-$250M per quarter moving forward, totaling over $1.1B for FY26. This huge buyback program (approx 5-6% of market cap) significantly de-risks the investment profile.
ALM & PLM Large Deal Wins
Despite the noise, the core remains sticky. Q1 saw the largest-ever deals for Codebeamer (ALM) and Onshape (Cloud CAD), along with a Windchill displacement in med-tech. RPO (Remaining Performance Obligations) increased >$550M YoY, indicating that while new logo velocity may be slowing, large enterprise commitments are deepening.
Macro Headwinds & Guidance Cushion
Management explicitly baked 'macro disruption' into the low end of the FY26 guidance (7% growth). They noted that while the pipeline is strong, deal cycles remain complex, and the divestiture could distract from joint pipeline opportunities. The flat net new ARR guidance for FY26 suggests they do not expect a macro recovery this year.
Other KPIs
Stable/Decelerating. Growth of +8.4% YoY. Excluding the divested Kepware/ThingWorx businesses, organic growth was +9.0%. This is the primary metric to watch, and it continues to trend down from double digits a year ago.
Stable. Up +13% YoY. Management maintained FY26 FCF guidance of ~$1.0B (pre-divestiture adjustment), showing that cash generation remains efficient even as top-line growth moderates.
Accelerating. Up 104% YoY. Heavily distorted by the upfront revenue recognition of multi-year deals (ASC 606) and a tax benefit. Do not use this as a proxy for business health.
Guidance
Decelerating. The midpoint (8%) is below the current quarter's 8.4%. Management calls this 'disciplined,' factoring in macro risks and divestiture distractions. Excluding the divestiture, the organic guide is 7.5% - 9.5%.
Stable. This implies ~17% YoY growth. Note: This figure will be adjusted downward to ~$840M post-divestiture (due to tax leakage and lost FCF from sold assets), but the underlying cash generation capability remains intact.
Decelerating. Down from 8.4% in Q1. This explicitly confirms that the bottom of the deceleration trend has not yet been reached.
Key Questions
Organic Growth Floor
With ARR growth decelerating to ~8% and guidance suggesting ~7.5% in Q2, where is the organic floor? Is the 'Intelligent Product Lifecycle' strategy sufficient to return to double-digit growth without the IoT component?
Cross-Sell Risks Post-Divestiture
Did the Kepware/ThingWorx portfolio act as a 'wedge' product for getting into factories? With that gone, does the sales motion for PLM/ALM into the manufacturing shop floor become harder?
GenAI Monetization Lag
Management talks about AI in Creo and ServiceMax, but when will this show up in Net New ARR? Is AI currently just a retention tool, or is there a specific timeline for material revenue uplift?